The Indian Competition Commission fines pharmaceutical companies for bid rigging in a public tender (GlaxoSmithKline, Sanofi)

CCI fines GSK and Sanofi for bid rigging* It has been quite a while since I posted an India update on Cartel Capers. This was partly due to the fact that the CCI has been relatively quiet on the cartel front for the last few months and partly because I have also been relatively busy with merger control work (which to many often comes across as quite drab compared to a juicy cartel case!). However, breaking this prolonged silence, the CCI recently published a decision imposing fines on GSK and Sanofi, two major global pharma players as they were found to have rigged bids in a government tender

Access to this article is restricted to subscribers

Already Subscribed? Sign-in

Access to this article is restricted to subscribers.

Read one article for free

Sign-up to read this article for free and discover our services.

 

PDF Version

Author

Quotation

Avinash Amarnath, The Indian Competition Commission fines pharmaceutical companies for bid rigging in a public tender (GlaxoSmithKline, Sanofi), 4 June 2015, e-Competitions Bulletin Burden of proof, Art. N° 74157

Visites 168

All issues

  • Latest News issue 
  • All News issues
  • Latest Special issue 
  • All Special issues